Publications

Secukinumab Demonstrated Sustained Retention, Effectiveness and Safety in a Real-World Setting in Patients with Moderate-To-Severe Plaque Psoriasis: Long-Term Results from an Interim Analysis of the Serena Study

AuthID
P-00W-VAA

Author(s)

Augustin, M

Sator, PG

von Kiedrowski, R

Conrad, C

Rigopoulos, D

Romanelli, M

Ghislain, PD

Torres, T

Ioannides, D

Aassi, M

Schulz, B

Jagiello, P

Group Author(s)

SERENA Study Grp

Document Type

Article in Press

Year published

2022

Published

in JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, ISSN: 0926-9959

Volume: 36, Issue: 10, Pages: 1796-1804 (9)

Indexing

Wos^®

Scopus^®

Crossref^®13

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1111/jdv.18329

Pubmed: 35696305

Scopus: 2-s2.0-85133775109

Wos: WOS:000820305600001

Source Identifiers

ISSN: 0926-9959

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Secukinumab Demonstrated Sustained Retention, Effectiveness and Safety in a Real-World Setting in Patients with Moderate-To-Severe Plaque Psoriasis: Long-Term Results from an Interim Analysis of the Serena Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Secukinumab Demonstrated Sustained Retention, Effectiveness and Safety in a Real-World Setting in Patients with Moderate-To-Severe Plaque Psoriasis: Long-Term Results from an Interim Analysis of the Serena Study

Useful Links

Get Help